Report error Found 73 with Last Name = 'plutizki' and Initial = 's'
Affinity DataIC50: 2nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: <10nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 23nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 37nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 40nMAssay Description:Inhibition of GSK3betaMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 48nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 50nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 71nMAssay Description:Inhibition of GSK3betaMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 90nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 90nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: 129nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 132nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 134nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 153nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 153nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 166nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 182nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: 195nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: 208nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: 215nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: 215nMAssay Description:Inhibition of GSK3betaMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 227nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 239nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 251nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 373nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 480nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 554nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 554nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 556nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: 556nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 657nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 920nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Johannes Gutenberg-UniversitäT Mainz
US Patent
Johannes Gutenberg-UniversitäT Mainz
US Patent
Affinity DataIC50: 920nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+3nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+3nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Johannes Gutenberg University of Mainz
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory con...More data for this Ligand-Target Pair
